Disease control and objective responsive rates in randomized phase II trials evaluating non-first-line chemotherapy for non-small cell lung cancer: a systematic review of 74 trials

Although objective response rate and disease control rate are commonly used as primary endpoints of lung cancer trials, it remains unclear whether objective response rate and disease control rate correctly reflect the overall survival in a non-small cell lung cancer phase II trial evaluating a non-f...

Descripción completa

Detalles Bibliográficos
Autores principales: Matsumoto, Hiromi, Horita, Nobuyuki, Ito, Kentaro, Ebina-Shibuya, Risa, Hara, Yu, Kobayashi, Nobuaki, Kaneko, Takeshi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AME Publishing Company 2021
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8182707/
https://www.ncbi.nlm.nih.gov/pubmed/34164275
http://dx.doi.org/10.21037/tlcr-20-1120

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8182707/
https://www.ncbi.nlm.nih.gov/pubmed/34164275
http://dx.doi.org/10.21037/tlcr-20-1120

Ejemplares similares